YM BioSciences Inc.
25 May 2006
YM BioSciences Inc. (the 'Company')
The Company announces that 5,675,287 common shares have been issued as partial
vendor consideration in conjunction with the acquistion of Eximias
Pharmaceutical Corporation. Application has been made for these shares to be
admitted to AIM.
This information is provided by RNS
The company news service from the London Stock Exchange